Logo do repositório
 
Publicação

Deep Learning for predicting disease progression of clinical endpoints in ALS

datacite.subject.fosEngenharia e Tecnologia::Engenharia Eletrotécnica, Eletrónica e Informáticapt_PT
dc.contributor.advisorMadeira, Sara Alexandra Cordeiro
dc.contributor.advisorGarcia, Nuno Ricardo da Cruz
dc.contributor.authorSilva, Lucas Barreto
dc.date.accessioned2023-05-23T17:07:40Z
dc.date.available2023-05-23T17:07:40Z
dc.date.issued2023
dc.date.submitted2022
dc.descriptionTese de Mestrado, Engenharia Informática, 2022, Universidade de Lisboa, Faculdade de Ciênciaspt_PT
dc.description.abstractAmyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease vastly known for its rapid progression, usually leading to death within a few years, by respiratory failure. Since there is no cure currently known, the main objective is treatment in order to improve symptoms and prolong survival. A treatment that is known to be effective, is Non-invasive Ventilation (NIV), being capable of extending life expectancy and improving quality of life. Therefore it is imperative to administrate it preemptively. However Amyotrophic Lateral Sclerosis (ALS) affects most muscles of the body, so there will exist many clinical conditions that require some kind of treatment. In this work, we propose two approaches that use deep learning to predict Amyotrophic Lateral Sclerosis (ALS) disease progression, to know when a patient should be treated or not for a given clinical endpoint. In the first approach, we use the various snapshots of the patients as input without taking into consideration the temporal dependence between the available features, so instead we use each assessment of the patient as a single instance to feed the models. In this approach, we propose the use of a MLP and a CNN, to predict the outcome for the time windows available (90, 180 and 365 days), using the instances mentioned before and perform class resampling on the training sets, using SMOTE on the minority class and Random Undersampling on the majority class. In order to have more data to train the models and have a balanced set, which helps achieving a better performing model on the test set. In the second approach, we take the snapshots of the patients and group them by the patient reference, and proceed to only used those that have length of 3 and 4. On the sequences of length 3, we performed padding in order to have the same length as the sequences of length 4, by simply taking the first instance of this sequence and use it as the first and second assessment on the sequences. We proceed to use the sequences to feed them into a LSTM model, and train for the several datasets and retrieve the scores obtained. On this approach we do not perform any type of class resampling, as the first approach does. The results obtained show some promising insights, on the first approach in which we use the instances of the patients, the preprocessing performed was one of the main factors to the great results obtained. On the second approach, which the temporal sequences of length 3 and 4 are used, the results obtained are not as promissing as the first approach, however there are still improvements that could be done.pt_PT
dc.identifier.tid203499590
dc.identifier.urihttp://hdl.handle.net/10451/57551
dc.language.isoengpt_PT
dc.relationPTDC/CCICIF/4613/2020pt_PT
dc.subjectALS Functional Rating Scalept_PT
dc.subjectData Imputationpt_PT
dc.subjectDeep Learningpt_PT
dc.subjectEsclerose Lateral Amiotróficapt_PT
dc.subjectVentilação não-invasivapt_PT
dc.subjectTeses de mestrado - 2022pt_PT
dc.titleDeep Learning for predicting disease progression of clinical endpoints in ALSpt_PT
dc.typemaster thesis
dspace.entity.typePublication
rcaap.rightsopenAccesspt_PT
rcaap.typemasterThesispt_PT
thesis.degree.nameMestrado em Engenharia Informáticapt_PT

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
TM_Lucas_Silva.pdf
Tamanho:
609.76 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: